Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
European Journal of Biochemistry|March 16, 1981
Chemical modifications of the active site of Streptomyces R61 DD-carboxypeptidaseN H Georgopapadakou, F Y Liu, D E Ryono, et al.Analytical Biochemistry|February 1, 1984
Streptomyces R61 DD-carboxypeptidase: hydrolysis of X-D-alanyl-D-alanine peptides measured by a fluorometric assayN H Georgopapadakou, F Y Liu, D E Ryono, et al.Biochemical and Biophysical Research Communications|May 30, 1989
Affinity purification of endothia protease with a novel renin inhibitor SQ 32,970J A Norman, D Little, C A Free, et al.Journal of Medicinal Chemistry|August 20, 1993
Activated ketone based inhibitors of human reninD V Patel, K Rielly-Gauvin, D E Ryono, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 1, 1989
Pharmacology of novel imidazole alcohol inhibitors of primate reninJ M DeForrest, T L Waldron, R S Oehl, et al.British Journal of Pharmacology|September 1, 1994
BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174K E Dickinson, R B Cohen, S Skwish, et al.Journal of Medicinal Chemistry|October 27, 1995
alpha-Hydroxy phosphinyl-based inhibitors of human reninD V Patel, K Rielly-Gauvin, D E Ryono, et al.Journal of Medicinal Chemistry|January 19, 1996
Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitorsJ A Robl, M P Cimarusti, L M Simpkins, et al.Journal of Pharmaceutical Sciences|August 1, 1996
Prodrugs of BMS-183920: metabolism and permeability considerationsM T Obermeier, S Chong, S A Dando, et al.Journal of Medicinal Chemistry|March 1, 1982
Angiotensin-converting enzyme inhibitors: importance of the amide carbonyl of mercaptoacyl amino acids for hydrogen bonding to the enzymeM E Condon, E W Petrillo, D E Ryono, et al.Pageof 2